At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PBM Psyence Biomedical Ltd
Not Yet Opened 12-22 16:00:00 EST
0.9080
-0.0920
-9.20%
盘后0.8624
-0.0456-5.02%
19:59 EST
High0.9959Low0.8523Vol1.46M
Open0.9946D1 Closing1.00Amplitude14.36%
Mkt Cap1.70MTradable Cap1.69MTotal Shares1.87M
T/O1.35MT/O Rate78.57%Tradable Shares1.86M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Correction: Investors Hope for Rate Cut Following Subdued Inflation as US Futures Mixed in Friday's Premarket Session
MT Newswires Live  ·  12-19
Correction: Investors Hope for Rate Cut Following Subdued Inflation as US Futures Mixed in Friday's Premarket Session
Psyence BioMed Wins Ethics Approval for PsyLabs Psilocybin in Phase IIb Cancer Trial
Reuters  ·  12-19
Psyence BioMed Wins Ethics Approval for PsyLabs Psilocybin in Phase IIb Cancer Trial
Psyence Biomed Announces Approval for Use of Psylabs’ Psilocybin Product in Phase Iib Clinical Trial
THOMSON REUTERS  ·  12-19
Psyence Biomed Announces Approval for Use of Psylabs’ Psilocybin Product in Phase Iib Clinical Trial
Psyence Biomedical Ltd: Study Remains on Track to Deliver Top-Line Results in 2026
THOMSON REUTERS  ·  12-19
Psyence Biomedical Ltd: Study Remains on Track to Deliver Top-Line Results in 2026
PBM Polytex Sells Land in Nagpur, India
MT Newswires Live  ·  12-17
PBM Polytex Sells Land in Nagpur, India
Psyence BioMed Reports Phase IIb Trial Progress and Strengthened Cash Position
Reuters  ·  12-09
Psyence BioMed Reports Phase IIb Trial Progress and Strengthened Cash Position
Psyence BioMed Launches Psilocybin Longevity Research Program
Reuters  ·  11-25
Psyence BioMed Launches Psilocybin Longevity Research Program
Psyence BioMed Takes Minority Stake in PsyLabs to Boost African Ibogaine Operations
Reuters  ·  11-22
Psyence BioMed Takes Minority Stake in PsyLabs to Boost African Ibogaine Operations
WellsCare Partners with SolnanoMed to Launch IASO and IASO Ultra in Thailand
prnewswire  ·  11-17
WellsCare Partners with SolnanoMed to Launch IASO and IASO Ultra in Thailand
Psyence BioMed Invests in PsyLabs to Establish Ibogaine Operations in Africa
Reuters  ·  11-12
Psyence BioMed Invests in PsyLabs to Establish Ibogaine Operations in Africa
Psyence Biomed Establishes Ibogaine Operations in Africa Through Strategic Investment in Psylabs
THOMSON REUTERS  ·  11-12
Psyence Biomed Establishes Ibogaine Operations in Africa Through Strategic Investment in Psylabs
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
Benzinga_recent_news  ·  11-12
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'
Psyence BioMed Doses Multiple Patients in Phase IIb Psilocybin Trial for Adjustment Disorder
Reuters  ·  11-06
Psyence BioMed Doses Multiple Patients in Phase IIb Psilocybin Trial for Adjustment Disorder
Psyence Biomed Doses Multiple Patients and Expands Clinical Sites in Phase Iib Study for Adjustment Disorder in Palliative Care
THOMSON REUTERS  ·  11-06
Psyence Biomed Doses Multiple Patients and Expands Clinical Sites in Phase Iib Study for Adjustment Disorder in Palliative Care
Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market
Benzinga  ·  11-05
Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market
Psyence BioMed Invests $3.5 Million in PsyLabs
Reuters  ·  11-03
Psyence BioMed Invests $3.5 Million in PsyLabs
Psyence Biomed Strengthens Strategic Partnership With Psylabs Through USD $3,500,000 Follow-on Investment
THOMSON REUTERS  ·  11-03
Psyence Biomed Strengthens Strategic Partnership With Psylabs Through USD $3,500,000 Follow-on Investment
The Pharmacy Stock That's Cheaper Than It Should Be
Motley Fool  ·  10-15
The Pharmacy Stock That's Cheaper Than It Should Be
BRIEF-Psyence Biomedical's chairman, Jody Aufrichtig, assumes role Of CEO
Reuters  ·  10-10
BRIEF-Psyence Biomedical's chairman, Jody Aufrichtig, assumes role Of CEO
Psyence Biomedical Ltd: Neil Maresky Has Transitioned From His Role as CEO and Director to Serve as Co’s Global Head, Clinical Development
THOMSON REUTERS  ·  10-10
Psyence Biomedical Ltd: Neil Maresky Has Transitioned From His Role as CEO and Director to Serve as Co’s Global Head, Clinical Development

Introduction

Company Name.
Psyence Biomedical Ltd
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.
Issue price:
--